Cargando…

Editorial: The role of one-carbon metabolism in cancer progression, therapy, and resistance

Detalles Bibliográficos
Autores principales:	Thakur, Abhimanyu, Hu, Xin, Zhao, Erhu, Lu, Chunwan, Liu, Yanqing, Rustagi, Yashika, Zhang, Kui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552637/ https://www.ncbi.nlm.nih.gov/pubmed/37810982 http://dx.doi.org/10.3389/fonc.2023.1286790

Ejemplares similares

Serine–glycine-one-carbon metabolism: vulnerabilities in MYCN-amplified neuroblastoma
por: Zhao, Erhu, et al.
Publicado: (2020)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Advances in highly active one-carbon metabolism in cancer diagnosis, treatment and drug resistance: A systematic review
por: Liu, Shuang, et al.
Publicado: (2022)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Editorial: Targeting cancer cell intracellular metabolism as a strategy against therapy resistance
por: Liu, Lingling, et al.
Publicado: (2023)

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
por: Kondoh, Hiroshi, et al.
Publicado: (2021)

Editorial: Redox metabolism: a double edge sword sustaining the adaptive resistance to therapy in cancer
por: Marengo, Barbara, et al.
Publicado: (2023)

Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers
por: Sun, Wei, et al.
Publicado: (2023)

Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers
por: Huang, Jun, et al.
Publicado: (2023)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

Editorial: The roles of immune cell homeostasis in cancer research and therapeutic response
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: The Role of lncRNA in Cancer Metabolism
por: Huang, Guo-Liang, et al.
Publicado: (2021)

Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
por: Zhang, Jing, et al.
Publicado: (2023)

Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: The role of iron in cancer progression
por: Hamaï, Ahmed, et al.
Publicado: (2022)

Editorial: Metabolic Plasticity of Cancer
por: Rodríguez-Enríquez, Sara, et al.
Publicado: (2020)

Editorial: Metabolic Rewiring in Leukemias
por: Noguera, Nelida I., et al.
Publicado: (2021)

Editorial: Sphingolipid metabolism and cancer
por: Ivanova, Margarita M., et al.
Publicado: (2022)

Editorial: Reviews in cancer metabolism
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2023)

Screening of MicroRNA as potential CardiomiRs in Rattus noveregicus Heart related Dataset
por: Rustagi, Yashika, et al.
Publicado: (2013)

Editorial: LncRNAs in Cancer Metastasis and Therapy Resistance
por: Ahmad, Aamir, et al.
Publicado: (2021)

Editorial: Overcoming drug relapse and therapy resistance in NSCLC
por: Parakh, Sagun, et al.
Publicado: (2023)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
por: Liu, Yanqing, et al.
Publicado: (2023)

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
por: Wang, Lishun, et al.
Publicado: (2023)

Editorial: The Role of Epigenetic Modifications in Cancer Progression
por: Fujimura, Atsushi, et al.
Publicado: (2021)

Editorial: The Role of Platelets in Cancer Progression and Malignancy
por: Schlesinger, Martin, et al.
Publicado: (2021)

Editorial: Influences in the progression of renal cell carcinoma
por: Bacchiani, Mara, et al.
Publicado: (2022)

Editorial: Molecular and immune influences in the progression of gliomas
por: Malik, Karan, et al.
Publicado: (2023)

Editorial: 365 days of progress in radiation oncology
por: Kinsella, Timothy J.
Publicado: (2023)

Editorial: 365 days of progress in cancer genetics
por: Ratajska, Magdalena, et al.
Publicado: (2023)

Editorial: Metabolism As a Therapeutic Target
por: Columbano, Amedeo, et al.
Publicado: (2017)

Editorial: Redox and Metabolic Circuits in Cancer
por: Rizza, Salvatore, et al.
Publicado: (2018)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Editorial: Proteomics and Its Applications in Cancer
por: Thakur, Suman S., et al.
Publicado: (2021)

Editorial: Metabolism Meets Function: The Multifaced Role of Metabolism in Cancer
por: Giacomini, Isabella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a75u7mjp32fdjqdrr8r11epjd5